Business
- News Home
- Other categories
-
Barclays tells customers to contact friends and family or foodbanks after IT glitch
Barclays has advised customers to seek help from friends and family or even contact food banks after a major IT glitch left some locked out of their accounts.
-
Honeymoon couple unable to access their money online as Barclays suffers major IT glitch
A newlywed couple say they have been locked out of their bank accounts while on their honeymoon as Barclays suffered a major IT glitch.
-
NatWest finalises £450m bonus pot as return to private ownership looms
NatWest Group is finalising plans to pay out close to £450m in bonuses for last year as it prepares for a return to full private ownership nearly 17 years after its bailout.
-
Donald Trump hits Canada, Mexico and China with tariffs - amid fears US consumers could suffer
Donald Trump has placed 25% tariffs on imports from Canada and Mexico and 10% tariffs on goods from China.
-
China has avoided the same tariffs as Mexico and Canada for now - and is taking Trump in its stride
President Donald Trump has been threatening increased tariffs on China for months and now he says he's delivering it.
-
Trump's changed tack to focus tariffs on Mexico and Canada - why?
We all know Donald Trump loves a tariff. Not long ago he said it was his favourite word in the English language.
-
Wine-lovers left to drown sorrows as tax hike hits cost of a bottle - but it's not all bad news for drinkers
Consumers will see the price of alcohol rise from Saturday when a hike in tax and duties comes into effect.
-
FTSE 100 reaches another record high as January is the best month in more than two years
The UK's benchmark stock index has reached another all-time high, in a month of record breaking.
-
AstraZeneca scraps £450m vaccine plant in Liverpool after Labour funding cut
AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government.
-
AstraZeneca move leaves Reeves under the weather
In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth.